论文部分内容阅读
目的:探讨三氧化二砷联合维甲酸(ATRA)治疗MDS的疗效。方法:31例MDS患者均采用三氧化二砷联合维甲酸等治疗。结果:RA+RAS组有效率87.1 %,RAEB+RAEB蛳T组有效率42.9 %。结论:三氧化二砷是一种治疗MDS的有效药物,尤其是在RA的治疗中有显著效果。
Objective: To investigate the efficacy of arsenic trioxide combined with retinoic acid (ATRA) in the treatment of MDS. Methods: All 31 MDS patients were treated with arsenic trioxide and retinoic acid. Results: The effective rate was 87.1% in RA + RAS group and 42.9% in RAEB + RAEB group. Conclusion: Arsenic trioxide is an effective drug for the treatment of MDS, especially in the treatment of RA.